China Blacklists Six Executives Linked to $4.2 Billion Fraud

(Bloomberg) -- China’s securities regulator blacklisted six executives for their role in a $4.2 billion accounting scandal at Kangmei Pharmaceutical Co., one of the country’s biggest drugmakers.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.